NEURO NEWS
Neurological News with information about conditions, treatments, current studies and breakthroughs.
TMS Therapy for Tic Disorder: Restoring Control and Confidence
Tic disorders, characterized by sudden, repetitive movements or sounds, can significantly impact daily life. While medications and therapy are traditional [...]
TMS Therapy for Tic Disorders
Are you or a loved one struggling with tic disorders, experiencing the disruptive and involuntary movements or vocalizations that characterize [...]
TMS Therapy: A New Hope for Addiction and Binge Eating at Countryside Neurology
Addiction and binge eating can have a significant impact on an individual's physical health, emotional well-being, and relationships. Finding effective [...]
TMS Therapy for Binge Eating at Countryside Neurology: A New Approach to Treating Binge Eating Disorder
Binge Eating Disorder (BED) is a serious condition that affects millions of people worldwide. It's characterized by recurrent episodes of [...]
The Impact of Vaping and E-Cigarettes on Brain Health: What You Need to Know
In recent years, vaping and the use of e-cigarettes have surged in popularity, especially among younger demographics. Marketed as a [...]
Exploring Neurodiversity: Embracing Differences in Brain Function at Countryside Neurology
In an evolving understanding of what it means to be 'normal', Countryside Neurology in the Greater Tampa Bay area embraces [...]
- Medicinal Signaling Cell Therapy Fast Tracked for Mild Alzheimer Disease July 29, 2024The investigational allogeneic cellular therapy is believed to impart anti-inflammatory, pro-vascular, and pro-regenerative effects.
- Endo Recalls Clonazepam ODT Due to Carton Label Displaying Incorrect Strength July 29, 2024The product is being recalled because the incorrect strength of 0.125mg is appearing on the carton labels.
- Investigational Gene Therapy for Parkinson Disease Gets Fast Track Status July 22, 2024AB-1005 is an investigational gene therapy based on AAV2 containing the human GDNF transgene.
- FDA Approves Aflibercept Biosimilar Ahzantive July 16, 2024Ahzantive is a vascular endothelial growth factor inhibitor.
- Ketamine May Reduce Cluster Headache Symptoms July 2, 2024Researchers sought to evaluate ketamine as a potentially promising treatment approach.
Get Social